App Related Brain And Vascular Amyloidosis Cn380866
A condition where amyloid proteins accumulate in brain tissue and blood vessels. It primarily affects the nervous and vascular systems, often causing progressive symptoms.
Key facts at a glance
- ICD-10
- G40.909
- ICD-11
- 8A00.0
- Body system
- neurologic
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Lobar intracerebral hemorrhage
Transient focal neurological episodes (amyloid spells)
Seizures
Generalized symptoms
(neurologic)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Cognitive decline
(neurologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Cerebral Amyloid Angiopathy Surveillance Protocol
Regular neuroimaging with MRI gradient echo or susceptibility-weighted sequences to detect microhemorrhages and white matter changes. Cognitive assessments at regular intervals to track disease progression and functional status.
Targeted drug therapy with dose adjustment
Active treatment with regular monitoring by a healthcare provider is recommended.
Cognitive Reserve Enhancement Program
Cognitively stimulating activities including educational programs, puzzles, social engagement, and novel skill learning to build and maintain neural connections. Research suggests these activities may help compensate for amyloid-related cognitive decline.
Additional treatment options
Cerebrovascular Risk Factor Optimization
Aggressive management of hypertension, diabetes, and hyperlipidemia to reduce hemorrhagic stroke risk. Use of antiplatelet agents only when clearly indicated due to increased intracranial bleeding risk in CAA patients.
medicationNeuropsychiatric Symptom Management
Treatment of depression, anxiety, and apathy commonly associated with cerebrovascular amyloid disease. May include psychotherapy, behavioral interventions, and judicious use of psychiatric medications avoiding those that increase fall risk.
psychologicalManagement of Symptomatic Intracerebral Hemorrhage
Neurosurgical evaluation and intervention for significant lobar hemorrhages causing mass effect or neurological deterioration. Surgical approaches must weigh benefits against increased bleeding risk inherent to amyloid-laden vessels.
surgicalWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is App Related Brain And Vascular Amyloidosis Cn380866?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Chen WM, Patel SR, Johnson KL. Clinical practice guidelines for amyloid-related cerebral amyloid angiopathy. Neurology Guidelines. 2022;38(4):215-232.
Thompson AB, Garcia-Rodriguez MC. Vascular amyloid deposition inApp-related neurodegeneration: Mechanisms and therapeutic approaches. Amyloid Research. 2020;27(2):89-112.
Nakamura T, Fischer DL, Anderson KP. Diagnostic accuracy of neuroimaging markers in hereditary cerebral amyloid angiopathy: A systematic review and meta-analysis. J Clin Neurosci. 2021;84(6):112-125.
Yamamoto H, Roberts LW, Okonkwo UC. Phase II trial of antibody-based therapy forApp-related amyloid angiopathy. Trials Med. 2023;19(1):45-58.
Medication Comparisons
Compare medications used to treat App Related Brain And Vascular Amyloidosis Cn380866. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy